Hereditary Cancer
Remote Testing
Know your genes, take control of your health
Genetic testing for prostate cancer looks at your DNA to personalize cancer treatment regardless of where you are in your journey.
Benefits of genetic testing
New life-sustaining treatment options are available for men with prostate cancer and a DNA mutation. Genetic testing is the only way to know if you qualify.
Certain DNA mutations increase the likelihood of a more aggressive cancer and this information should be used when considering active surveillance. 1, 2
Genetic testing informs family members (blood related) if they are at an increased risk for developing certain cancers.
How it works
Request your Myriad Genetics test kit
Kits are mailed directly to your house and generally arrive in 5-7 days.
Work with provider to obtain sample
Remote testing options are available and Myriad is committed to help you understand your options.
Your genes are analyzed at our state-of-the-art facility
Myriad looks at your unique genetic information using the latest in sequencing technology.
Results available in around 2 weeks
Once results are available, they are sent securely to your doctor’s office. Your doctor will then help you understand your results and own your health.
Frequently asked questions
97% of people have coverage for genetic testing, with 3/4 of all patient’s paying $0. For those with an out-of-pocket cost – the average is <$60.
Myriad offers broad payment plans and financial assistance to both insured and uninsured patients may meet financial and medical eligibility criteria are met.
Myriad has tested and protected over 5 million test results and is committed to keeping your results private and secure. Learn more about the Myriad Privacy Policy.
Your sample must be collected by a physician. Find a physician in your area here.
Submit the form below to receive your testing kit
Please allow 7-10 business days for your kit to ship.
Please note: The test request form inside your Myriad Genetics BRACanalysis CDx™ Test kit will need to be completed and include a signature from your healthcare provider before your test can be processed.
References:
- NCCN Guidelines Version 2.2021 Prostate Cancer
- Gomella LG et al. Introduction to the 2019 Philadelphia Prostate Cancer Consensus Program: Implementation of Genetic Testing for Inherited Prostate Cancer. Can J Urol. 2019;26(5 Suppl 2):1-4